Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 398 of 6351
-
New study to see if heart procedure beats standard care for AF and heart failure
Disease control Not yet recruitingThe clinical equipoise in the treatment of Atrial Fibrillation (AF) in patients with Heart Failure with mildly reduced Ejection Fraction/Heart Failure with Preserved Ejection Fraction (HFmrEF/HFpEF) reflects the scarcity of randomized trials on different treatment modalities. By …
Sponsor: Tulane University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Exoskeleton and spinal zaps may rebuild muscle and bone after paralysis
Disease control Not yet recruitingImmobilization following spinal cord injury (SCI) results in muscle and bone loss below the level of injury, which ultimately predisposes to fracture at several sites throughout the legs and can lead to several medical complications that can devastate quality of life. There is a …
Sponsor: Bronx VA Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Stool test vs. colonoscopy: new trial aims to prevent colon cancer in High-Risk patients
Prevention Recruiting nowThe ULTRA-SAFE clinical trial is a prospective, randomized study designed to address the limitations of current "one-size-fits-all" colorectal cancer surveillance guidelines. While international standards recommend a three-year follow-up colonoscopy for all high-risk patients, da…
Sponsor: National Taiwan University Hospital • Aim: Prevention
Last updated Aug 28, 2026 00:00 UTC
-
Can a gout drug and a blood thinner stop second strokes?
Disease control Not yet recruitingThe ARCHIMEDES study (Anti-inflammatory and anti-thRombotic therapy with colCHicine and low dose rIvaroxaban for Major adverse cardiovascular Events reDuction in ischEmic Stroke) will be a randomized, double-blind, 2x2 factorial clinical trial, which will include at least 3000 an…
Phase 4 • Sponsor: Brazilian Clinical Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New hope for blistering skin diseases: drug targets antibodies to heal wounds
Disease control Not yet recruitingThe study objective is to see if IV Efgartigimod and Vyjuvek treatment in Recessive Dystrophic Epidermolysis Bullosa (RDEB) and IV Efgartigimod treatment in Epidermolysis Bullosa Acquisita (EBA) improves wound healing and affects the levels of C7 antibody levels in serum. Fewer …
Phase 1/2 • Sponsor: M. Peter Marinkovich • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New hope for rare, painful skin disease: experimental drug EPN-701 enters phase 2 trial
Disease control Not yet recruitingCalciphylaxis is a rare but serious condition that leads to painful skin lesions. At present, there is no approved treatment for calciphylaxis. This research study is planned to examine the potential benefits of a new treatment (EPN-701) in patients with calciphylaxis. The presen…
Phase 2 • Sponsor: Sagar U. Nigwekar, MD, MMSc • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New CRISPR test could speed up sepsis diagnosis and save lives
Diagnosis Not yet recruitingThis study is a prospective, multicenter, integrated trial designed to evaluate, from the perspectives of diagnostic performance and clinical utility, whether a diagnostic and treatment strategy based on the NuRapid-CRISPR rapid pathogen detection technology can reduce the 28-day…
Sponsor: Shanghai 10th People's Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:31 UTC
-
New drug aims to stop deadly complication in leukemia therapy
Prevention Not yet recruitingThis study is to assess the efficacy and safety of Lisaftoclax for prevention of DS in APL patients undergoing ATRA/ATO induction regimen.
Phase 2/3 • Sponsor: The Affiliated People's Hospital of Ningbo University • Aim: Prevention
Last updated Jul 02, 2026 00:00 UTC
-
Hope for Huntington's: new drug aims to slow decline in major trial
Disease control Recruiting nowThe goal of this clinical trial is to learn if pridopidine can slow the clinical decline of Huntington's Disease (HD) in adult participants. It will also inform about the safety of pridopidine. The main questions the study aims to answer are: Does pridopidine slow the overall w…
Phase 3 • Sponsor: Prilenia • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Promising drug cocktail eyed for Tough-to-Treat urinary cancer
Disease control By invitation onlyThe combination of Enfortumab Vedotin and Pembrolizumab has substantially improved outcomes for patients with advanced urothelial carcinoma and has emerged as a new standard of care in the first-line setting. However, data specifically regarding its use in patients with Upper Tra…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Promising drug cocktail aims to save voice boxes in throat cancer patients
Disease control Recruiting nowThis clinical trial aims to evaluate the efficacy and safety of Becotatug Vedotin (EGFR-ADC) in combination with Pucotenlimab(Anti-PD-1 Monoclonal Antibody) as neoadjuvant therapy for patients with Resectable Locally Advanced Hypopharyngeal Squamous Cell Carcinoma. The primary o…
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Could less radiation be enough for some lymphoma patients?
Disease control Recruiting nowThis study is designed to evaluate the efficacy and safety of reduced-intensity radiotherapy for stage I/II low-risk nasal-type NK/T-cell lymphoma that has achieved complete remission after chemotherapy.
Phase 2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Brain scans may end guesswork in treating stubborn depression
Disease control Not yet recruitingDepression is one of the leading causes of disability worldwide. Common treatments like antidepressant medications and talk therapy work well for some people, but many others do not improve, even after trying multiple treatments. This study will investigate two alternative treat…
Phase 4 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New lens design aims to stop nearsightedness before it starts in children
Prevention Not yet recruitingMyopia is one of the most common visual impairments worldwide.This not only poses long-term risks to individual health but also imposes significant medical and economic burdens on society. \[6\] Therefore, delaying the onset of myopia and effectively controlling its progression h…
Sponsor: He Eye Hospital • Aim: Prevention
Last updated Jul 08, 2026 00:00 UTC
-
Video Game-Like therapy could replace eye patches for lazy eye in kids
Disease control Not yet recruitingThis study will evaluate whether augmented reality training is effective and safe for treating unilateral amblyopia after congenital cataract surgery in children. Children aged 5 to 12 years with unilateral amblyopia after congenital cataract surgery will be enrolled from three …
Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New drug cocktail targets tough esophageal cancer
Disease control Not yet recruitingThis study is a prospective, single-arm, single-center Phase Ib clinical trial of Becotatug Vedotin in combination with cisplatin and concurrent radiotherapy for locally advanced esophageal squamous cell carcinoma. The primary objectives are to investigate the maximum tolerated d…
Phase 1 • Sponsor: Hebei Medical University Fourth Hospital • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New ultrasound technique could reveal hidden blood vessels in liver tumors
Diagnosis Not yet recruitingThe macroscopic vascular supply of liver tumors varies considerably according to histological subtype, lesion size, and disease stage. Current clinical imaging modalities primarily characterize liver tumors based on their macroscopic vascular perfusion patterns. Conventional colo…
Sponsor: Eastern Hepatobiliary Surgery Hospital • Aim: Diagnosis
Last updated Jul 18, 2026 00:00 UTC
-
Period blood may offer a needle-free HPV test — a trial puts it to the test
Diagnosis Not yet recruitingThis study is evaluating whether human papillomavirus (HPV) can be accurately detected from self-collected menstrual blood samples. Participants who have had routine clinical HPV testing within the previous 90 days will collect a menstrual blood sample at home using a study-provi…
Sponsor: Samantha Batman • Aim: Diagnosis
Last updated Jul 31, 2026 00:00 UTC
-
Can a cholesterol-lowering combo also shrink fatty liver in diabetic heart patients?
Disease control Not yet recruitingCardiovascular diseases (CVDs) remain the leading cause of death globally, with a dominant contribution from atherosclerotic CVD (ASCVD). * Percutaneous coronary intervention (PCI) is a key method for revascularization in ASCVD patients, improving their prognosis. With the conti…
Phase 3 • Sponsor: Assiut University • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Can a single spinal injection transform Post-Surgery pain relief?
Symptom relief Recruiting nowThis study aims to compare the efficacy of intrathecal morphine and intrathecal dexmedetomidine in reducing pain following lumbar spine fixation surgeries.
Sponsor: Tanta University • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC